US20040199262A1 - Prosthesis having a sleeve valve - Google Patents

Prosthesis having a sleeve valve Download PDF

Info

Publication number
US20040199262A1
US20040199262A1 US10827957 US82795704A US2004199262A1 US 20040199262 A1 US20040199262 A1 US 20040199262A1 US 10827957 US10827957 US 10827957 US 82795704 A US82795704 A US 82795704A US 2004199262 A1 US2004199262 A1 US 2004199262A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
sleeve
prosthesis
stent
tubular
end
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10827957
Inventor
Kulwinder Dua
Scott Moore
John Karpiel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cook Endoscopy
Original Assignee
Cook Endoscopy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2002/044Oesophagi or esophagi or gullets

Abstract

Disclosed is a pressure sensitive prosthesis (10) that includes a tubular member (11) having a passageway (12) extending therethrough and a sleeve (13) attached about one end of the tubular member. The sleeve functions as a one-way valve to permit fluid flowing through the sleeve lumen (15) in a first direction (17) and under a first pressure, while collapsing in response to fluid flowing in a second direction 18 where the pressure that exceeds that of the first direction or pressure. One aspect of the invention includes an esophageal anti-reflux expandable prosthesis wherein the sleeve is adapted to invert back through the tubular stent frame to permit belching or vomiting (fluid or materials under a third, significantly higher pressure). Another aspect of the invention includes a tubular drainage stent (60), such as a biliary or urethral stent in which the sleeve opens to permit passage of fluids, then collapses to prevent retrograde flow.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • [0001]
    This application claims priority of provisional application Serial No. 60/211,753, filed Jun. 14, 2000, and is a continuation-in-part of co-pending U.S. patent application Ser. No. 09/386,173, filed Aug. 31, 1999, which claims priority to provisional application Serial No. 60/098,542, filed Aug. 31, 1998.
  • TECHNICAL FIELD
  • [0002]
    This invention relates generally to medical devices and, in particular, to an indwelling valved prosthesis.
  • BACKGROUND OF THE INVENTION
  • [0003]
    Anti-reflux esophageal prosthesis or stents are typically placed in the lower esophagus and through the lower esophageal sphincter to maintain the patency thereof due to the presence of a cancerous tumor commonly found in the vicinity thereof. The cancerous tumor growth typically impinges the flow of food and fluids through the esophagus. Lower esophageal cancer in the United States presently occurs at the rate of approximately 12,000 patients per year. The incidence in the United States is approximately 5.1 per 100,000 people, which is rising particularly in white male patients. Esophageal prosthesis or stents are typically utilized in these cancerous patients. However, these devices are not FDA approved for benign tumors which also cause blockage or partial stenosis of the esophagus. Esophageal prosthesis or stents are utilized in Europe and other countries for benign tumor conditions, but not in the United States at this time.
  • [0004]
    A problem with esophageal prosthesis or stents is that fluid from the stomach flows into the mouth of the patient when in a prone position. In an attempt to solve this problem, a number of esophageal prosthesis or stents utilize a one-way valve such as a duck-bill or reed-type valve in which only food or fluid from the esophagus flows into the stomach in only an antegrade or forward direction. However, these one-way anti-reflux prosthesis or stents present another problem. When the patient wants to belch or vomit, he/she is prevented from doing so, because the one-way valve prevents backward flow in the retrograde direction. Such condition is not only painful to the patient, but can also lead to more complicated medical conditions.
  • [0005]
    There are other anatomical sites, such as the biliary tree or genitourinary system in which a prosthesis may be placed to maintain an open lumen for passage of bodily fluids, thereby creating risk of undesirable retrograde flow and/or migration of pathogenic organisms which could lead to infection or other problems, such as obstruction of the stent. When a drainage stent or catheter is placed across a sphincter or natural stricture at the opening to a bodily passage, the sphincter or stricture cannot fulfill its normal function of restricting retrograde flow or migration. What is needed is a prosthesis and one-way valve that can effectively regulate antegrade and retrograde flow in response to the normal flow rates and pressures that exist across the site in which the prosthesis is placed.
  • SUMMARY OF THE INVENTION
  • [0006]
    The foregoing problems are solved and a technical advance is achieved in an illustrative prosthesis having a sleeve which permits antegrade flow under a first pressure through the sleeve, and collapses in response to a second flow or pressure that is greater than the first flow or pressure.
  • [0007]
    In one aspect of the invention, the prosthesis comprises an anti-reflux esophageal prosthesis in which a sleeve extending from a tubular frame thereof inverts through the passage of the tubular frame and allows stomach gas or vomit to flow in a retrograde direction when the pressure in the stomach exceeds a given level. In the antegrade or downward position, the sleeve collapses and prevents the reflux of stomach gas and fluid from flowing through the esophagus and into the mouth of the patient. The collapsible sleeve functions as a one-way valve and allows the patient to ingest or pass liquid and food therethrough and into the stomach. In addition, the tubular frame of this advantageous anti-reflux esophageal prosthesis maintains the patency of the lower esophagus and sphincter particularly when a cancerous tumor impedes fluid flow through the esophagus.
  • [0008]
    In another advantageous aspect of the present invention, the tubular frame of the anti-reflux esophageal prosthesis includes a plurality of self-expanding zig-zag stents. The compressed stents along with the sleeve are positioned in an delivery catheter which is orally passed through the esophagus and lower sphincter. The prosthesis is then deployed from the delivery catheter with, for example, a dilator or pusher catheter that is inserted in the lumen of the delivery catheter. The deployed, self-expanding stents readily expand to engage the esophagus and lower sphincter and maintain them in a patent condition.
  • [0009]
    The self-expanding stents of the tubular frame are also advantageously flared at each end of the tubular frame to prevent antegrade and retrograde migration of the expanded prosthesis. To further prevent migration of the zig-zag stents with respect to each other, a filament is circumferentially positioned through closed eyelets at the bends of adjacent zig-zag stents. The filaments are also utilized advantageously to control the radial expansion and the flared configuration of the stents positioned at the ends of the tubular frame.
  • [0010]
    The pressure needed to collapse or invert the one-way valvular sleeve is a function of the sleeve material, its wall thickness and length extending from the distal end of the tubular frame. Depending on the anatomical size of the human or veterinary patient, the sleeve can extend from the end of the frame for a length in a range of from 0.0 to 20 cm, preferably in a range of 5 to 15 cm; and more preferably in length of approximately 10 cm in a human patient or 8 cm in a veterinary patient as experimentally derived therefor. The sleeve material also advantageously includes a material of polyurethane, silicone, polyamides, other urethanes or any biocompatible material that is flexible and acid resistant. The sleeve material can have an advantageous thickness of 0.005″ through 0.008″.
  • [0011]
    This thickness is at the portion covering the frame itself. The sleeve extending from an end of the frame comprises a material having a thickness in a range of 0.0015″ to and including 0.004″ and preferably approximately 0.002″. Advantageously, the length of the sleeve is made long enough so that it can be readily shortened to accommodate individual anatomical situations.
  • [0012]
    In another aspect of the invention the collapsible sleeve is attached to a tubular drainage stent, such as a biliary stent, to advantageously prevent reflux of intestinal contents and the associated bacteria into the passage of the stent. These bacteria are known to promote the formation of biofilm which can lead to occlusion of the stent. With the stent placed in the biliary tree for maintaining patency of the bile or pancreatic duct and the Papilla of Vater, the sleeve extends down into the duodenum to provide a one-way valve for the flow of bile. When bile is not being secreted, the sleeve advantageously collapses to prevent backflow of material from the duodenum, a situation which might otherwise occur in a biliary stent without a closure means. Tubular drainage stents for placement in the ureters or urethra can include either a sleeve extending from one end to permit urine flow and prevent retrograde flow or pathogen migration toward the kidneys or bladder, or the sleeve may be located completely within the lumen of the drainage stent with one end of the sleeve being bonded or otherwise attached to the inner walls of the lumen.
  • BRIEF DESCRIPTION OF THE DRAWING
  • [0013]
    [0013]FIG. 1 depicts a pictorial view of an illustrative embodiment of a pressure sensitive anti-reflux esophageal prosthesis of the present invention;
  • [0014]
    [0014]FIG. 2 depicts an enlarged cross-sectional view of a sleeve about a cylindrical wire of a flared stent of the esophageal prosthesis taken along line 2-2 of FIG. 1;
  • [0015]
    [0015]FIG. 3 depicts an enlarged partially sectioned view of the adjacent ends of interconnected stents of the prosthesis of FIG. 1;
  • [0016]
    [0016]FIG. 4 depicts a two piece mandril that is used to apply the sleeve material to the prosthesis of FIG. 1;
  • [0017]
    [0017]FIG. 5 depicts the esophageal prosthesis of FIG. 1 deployed in the lower esophagus of a patient, and, in particular, through the lower esophageal sphincter and a cancerous tumor;
  • [0018]
    [0018]FIG. 6 depicts the anti-reflux esophageal prosthesis of FIG. 1 in a collapsed state in a delivery catheter;
  • [0019]
    [0019]FIG. 7 depicts the delivery catheter of FIG. 6 positioned in the lower esophagus, sphincter, and tumor of a patient;
  • [0020]
    [0020]FIG. 8 depicts an in-vitro barrier reflux curve for an anti-reflux esophageal prosthesis of the present invention;
  • [0021]
    [0021]FIGS. 9 and 10 depict the percent of fraction time of standard and anti-reflux esophageal prosthesis utilized in an evaluation of the present invention;
  • [0022]
    [0022]FIG. 11 depicts a pictorial view of an embodiment of a tubular drainage prosthesis of the present invention;
  • [0023]
    [0023]FIG. 12 depicts a cross-sectional view of a second embodiment of a tubular drainage prosthesis;
  • [0024]
    [0024]FIG. 13 depicts the prosthesis of FIG. 11 positioned in the common bile duct of a patient;
  • [0025]
    [0025]FIG. 14 depicts a side view of the prosthesis of FIG. 11 mounted on a delivery system;
  • [0026]
    [0026]FIG. 15 depicts a side view of one end of a valved prosthesis that includes a pigtail configuration; and
  • [0027]
    [0027]FIG. 16 depicts a laterally sectioned view of a valved prosthesis in which the sleeve is affixed with the lumen.
  • DETAILED DESCRIPTION
  • [0028]
    [0028]FIGS. 1-14 depict exemplary prostheses of the present invention comprising a tubular member 11 with a passage 12 therethrough, and a thin, flexible sleeve 13 extending from the tubular member 11. The sleeve 13, which also has a passage 15 therethrough, is configured to allow the flow of liquid or other materials moving under a first pressure until the flow and pressure are lessened where they are exceeded by the second, back pressure of the drainage environment, at which time the sleeve 13 collapses to prevent the ingress of fluids of materials into the tubular member.
  • [0029]
    [0029]FIG. 1 depicts a pictorial view of an illustrative, preferred embodiment of pressure sensitive anti-reflux esophageal prosthesis 10 of the present invention. The prosthesis includes a tubular frame 11 of a plurality 19 of self-expanding, zig-zag wire stents 20, 21, and 23 covered by a polyurethane sleeve 13 that is disposed around and extends along entire length 27 of the tubular frame. The sleeve also extends from distal end 14 of the self-expanding tubular frame and has a lumen 15 extending longitudinally therethrough. Lumen 15 of the sleeve also communicates with passage 12 of the tubular frame. When the prosthesis is positioned in the lower esophagus and through the lower sphincter of a patient, lumen 15 in lower portion 28 of the sleeve collapses upon itself due to wetting by gastric juices, fluid or saliva flowing therethrough from the esophagus in a first direction 17. As a result, sleeve 13 is in a collapsed position and acts as a one-way valve into the stomach, thereby preventing the reflux of gastric fluid from flowing in a retrograde manner through the prosthesis and esophagus and into the mouth of the patient, referred to herein as the second direction 18. However, fluid readily flows in the opposite (first) direction 17 from the esophagus and through the one-way valve sleeve into the patient's stomach.
  • [0030]
    Tubular frame 11 includes plurality 19 of self-expanding stents 20, 21, and 23 that are interconnected circumferentially by filament 24 about adjacent ends 25 and 26 of the stents. In this illustrative embodiment, the tubular frame includes four self-expanding, zig-zag wire metal stents of the Gianturco type as described in U.S. Pat. No. 4,580,568, which is incorporated by reference herein. Tubular frame includes first and second flared stents 20 and 21 positioned at distal and proximal ends 14 and 22 with first and second cylindrical stents 23 positioned therebetween. By way of example, first and second flared stents 20 and 21 have a minimum diameter of 18 mm and a flared diameter of approximately 25 mm. These diameters are nominal diameters for the stents and can be customized to meet the particular demands of any human or veterinary patient. The diameter of the flared end is maintained by end filament 29. The minimum diameter of the flared stents along with the nominal diameter of the cylindrical stents is maintained by interconnecting filaments 24. The interconnecting and end filaments 24 and 29 are, for example, 3/0 diameter mononylon suture material. The first and second flared stents 20 and 21 are positioned below and above the lower esophageal sphincter and prevent the migration of the prosthesis in either the antegrade or retrograde direction with respect to the esophagus. The flared proximal stent along with the cylindrical stents 23 also expand against any tumor that is in the region of the lower esophagus and maintains the patency of the lower esophageal lumen.
  • [0031]
    Flared stents 20 and 21 are, for example, formed from commercially available Series 304 stainless steel cylindrical wire having a diameter of approximately 0.015″. The wire is formed into a zig-zag pattern of which the ends are joined together using, for example, a metal sleeve and soldered together using silver/tin solder. However, other ways of forming a closed zig-zag configuration that resembles at least a partially tubular shape is contemplated. The flared or maximum diameter of the flared stents is approximately 25 mm with the minimum diameter at approximately 18 mm. Interconnecting cylindrical stents 23 are also formed from the same cylindrical wire and have a nominal diameter of approximately 18 mm matching that of the minimum diameter of the flared stents. The length of the individual stents is approximately 2 cm. The overall length of the tubular frame can range from 8 to 14 cm in 2 cm increments. These 2 cm increments are typically provided by increasing the number of interconnecting cylindrical stents 23.
  • [0032]
    Sleeve 13 preferably comprises a polyurethane material or other liquid impermeable material that does not degrade in the presence of fluids or gastric material that comes in contact therewith. The sleeve is disposed around and extends at least partially around tubular frame 11. Preferably, the sleeve extends the entire length of the frame and extends longitudinally from distal end 14 of the tubular frame. The length of the sleeve material extending from the distal end of the tubular frame can range from 0 through 20 cm, preferably 5 to 15 cm, and more preferably 10 cm. The length of the sleeve material can be individually customized by the physician depending on the anatomy of the patient. Experimental data has indicated that dogs typically utilize a 7 cm length of sleeve material. Human patients are expected to utilize a sleeve length of 8 or 9 cm. However, the length can again be modified by the physician to meet the particular anatomy of the patient. The wall thickness of the sleeve material disposed around the tubular frame is approximately 0.006″ thick. The thickness of the sleeve material along lower portion 28 of the sleeve is approximately 0.002″ thick.
  • [0033]
    The sleeve material preferably includes a medical grade polyurethane material; although silicone, nylon, polyamides such as other urethanes, or other biocompatible material that is flexible and acid resistant are also suitable materials. In particular, the polyurethane of the present invention is a medical grade polyurethane material grade EG-80A material commercially known as TECOFLEX® polyurethane material from Thermedics, Incorporated, Woburn, Mass.
  • [0034]
    [0034]FIG. 2 depicts an enlarged sectioned end view of sleeve 13 about cylindrical wire 30 of flared stent 20 of FIG. 1 along the line 2-2. As shown, the thickness of the sleeve material is approximately 0.006″, whereas the thickness of the sleeve material along lower or distal portion 28 thereof is preferably and approximately 0.002″. The thickness of sleeve material above distal portion 28 ranges from 0.005″ through 0.008″. Experimental data has indicated that the sleeve material along distal portion 28 still collapses at 0.004″ wall thickness so as to effectively form a one-way valve. Closure of the one-way valve sleeve material occurs at thicknesses above 0.004″; however, closure does not occur on a guaranteed basis each time. The thickness of the sleeve wall material below 0.0015″ presents a problem of tearing particularly when inserting the prosthesis into a delivery catheter.
  • [0035]
    [0035]FIG. 3 depicts an enlarged partially sectioned view of adjacent ends 25 and 26 of interconnected stents 20 and 23 of FIG. 1. Bends 31 of cylindrical wire 30 are formed into a keyhole configuration with silver solder 32 interconnecting the wire arms, thereby forming an aperture or eyelet 33. Interconnecting filament 24 is positioned through each eyelet and wound around at least once to aid in fixing the diameter of the expandable stents. One interconnecting or end filament is used at the end of each stent and tied at the loose ends with suture knot 34.
  • [0036]
    [0036]FIG. 4 depicts two piece mandril 35 that is used to apply sleeve material 13 to the prosthesis of FIG. 1. The mandril includes sleeve portion 36 and upper frame portion 37 that are interconnectable with, for example, threaded rod 38 and internally threaded channel 39. In use, the tubular frame including the plurality of self-expanding wire stents are positioned end-to-end and interconnected using interconnecting filament 24. The end filament is also positioned through the eyelets of the flared stents to control the maximum diameter thereof. The mandril has a minimum inner diameter matching that of the inside diameter of the inner stents and a flared diameter matching that of the flared stents. Extending from the ends of the flared portions, the mandril assumes the inner diameter of the one-way valve sleeve material. The assembled tubular frame is positioned between the upper frame portion of the sleeve portion of the mandril. The two portions of the mandril are then interconnected, thereby filling up the passage of the tubular frame. The tubular frame is then dipped into a slurry material of polyurethane to form an initial 0.004″ thickness over the entire length of the tubular frame. The mandril and covered tubular frame are then dipped in the slurry material at least one additional time to form the desired thickness of the sleeve material over mandril sleeve portion 36. After the slurry material cures, the two portions of the mandril are disconnected to form the anti-reflux esophageal prosthesis.
  • [0037]
    [0037]FIG. 5 depicts esophageal prosthesis 10 deployed in lower esophagus 40, and, in particular, through lower esophageal sphincter 41 and cancerous tumor 42. Distal flared stent 20 typically extends into the stomach along with sleeve 13. Flared stent 21 is positioned proximal to the sphincter and tumor, whereas the interconnected cylindrical stents are typically positioned through the sphincter and tumor. The flared stents 20 and 21, again, prevent a migration of the prosthesis in the esophagus. The lower or distal portion 28 of sleeve 13 extends into stomach 43. The lumen of the lower sleeve portion readily collapses when in contact with any external fluid applied thereto. However, any liquid or food is readily passed in an antegrade direction through the esophageal stent and into the stomach. As a result, one-way valve sleeve 13 opens to provide flow in the antegrade direction. Conversely, any fluids or food material 44 are prevented from flowing into the retrograde direction due to the collapsed lumen of sleeve 13. However, when the pressure of the gas or fluid in the stomach builds so as to cause the patient to belch or vomit, sleeve 13 will invert and extend in an antegrade direction through the lumen of the tubular frame as shown by phantom lines 45. In this position, gastric fluid and matter flows in the retrograde direction to relieve the patient. The length of distal portion 28 of the sleeve and the thickness thereof control the pressure at which the distal portion of the sleeve inverts through the tubular frame.
  • [0038]
    Self-expanding esophageal prosthesis are increasingly being used for palliation of malignant dysphagia. They can predispose to significant gastroesophageal reflux, including risk of aspiration, when deployed across the gastroesophageal junction. A study was performed to evaluate the anti-reflux efficacy of a esophageal prosthesis of the present invention to prevent reflux. A model EZS 21-8 from Wilson-Cook Inc., Salem, N.C. (16 mm diameter) was modified by extending its polyurethane covering 7 cm beyond its distal metal cage so as to form a “windsock” or collapsible sleeve. The pressure required to invert the windsock or collapsible sleeve into the tubular frame (reflux barrier) was determined by attaching the proximal end of the prosthesis to a hollow graduated tube and vertically inserting the stent under water until the windsock inverted. The pressure required to revert the windsock or collapsible lumen to its original one-way position was determined by pouring water into the lumen of the prosthesis. In-vivo evaluation was done in two esophagostomized dogs (male-18 kg, female-16 kg) and prosthesis insertion, positioning, and removal done by standard endoscopic and fluoroscopic techniques. Two site ambulatory esophageal pH monitoring (Synectics Medical) was performed at 5 cm and 10 cm above the gastroesophageal function. Each dog was studied twice using the standard model EZS 201-8 prosthesis and twice using the modified prosthesis (mean recording time per session 18.7+/−1 SE and 17+/−3 hours respectively). The results indicated that the windsock modification posed no difficulty in mounting or deploying the prosthesis using a currently available delivery system. Resistance to antegrade flow was minimal as even a drop of water put into the prosthesis easily passed through the windsock and both the dogs drank all the Ensure (4 cans per session) given to them irrespective of the type of prosthesis used. The pressure (cm of water) to overcome the reflux barrier was 15.7+/−0.3 SE and that to revert an inverted windsock or collapsible lumen was 0.4+/−0.03 SE. Results of the pH monitoring (mean +/−SE) is depicted in Table 1.
    TABLE 1
    Recording Standard Stent Anti-reflux Stent
    site (cm) above GEJ 5 10 5 10
    Number of reflux 229 ± 25″  56 ± 9@ 9.7 ± 7*   8 ± 5@
    episodes
    Fraction time pH  60 ± 5* 7.6 ± 2@ 0.7 ± 0.3* 0.2 ± 0.1@
    <4 (%)
  • [0039]
    The conclusions reached in the experiment were that a modified self-expanding metal esophageal prosthesis is highly effective in preventing reflux. The ability of the windsock or collapsible lumen sleeve 13 to invert at higher pressure gradients can allow patients to belch or vomit. Reversion to anti-reflux position requires minimal pressure and can be achieved by a water swallow. Further studies are indicated in FIGS. 8-10.
  • [0040]
    [0040]FIG. 6 depicts anti-reflux esophageal prosthesis 10 of FIG. 1 in a collapsed state in delivery catheter 46. Sleeve material 13 is positioned at the distal end of the delivery catheter. The prosthesis is drawn into the delivery catheter with a drawstring attached at the proximal end of the prosthesis. The drawstring and prosthesis are inserted through lumen 47 of the catheter by collapsing the tubular frame and then pulling the prosthesis into the distal end of the delivery catheter with the drawstring. To deploy the collapsed prosthesis from the delivery catheter, a pusher catheter 48 is positioned proximally in lumen 47 to engage the proximal end of the wire tubular frame 11.
  • [0041]
    [0041]FIG. 7 depicts delivery catheter 46 of FIG. 6 positioned in lower esophagus 40, sphincter 41, and tumor 42 of a patient. The distal end of the delivery catheter extends into stomach 43. As shown, the pusher has been placed in the lumen of the delivery catheter and engages the proximal end of prosthesis 10. As shown, sleeve 13 and flared distal stent 20 have been deployed from the distal end of the catheter. After the sleeve and distal flared stent 20 of the prosthesis have been deployed, the delivery catheter is partially withdrawn so as to engage the flared stent with the neck of the stomach about sphincter 41. Once positioned, the delivery catheter is pulled back while maintaining the position of the pusher catheter therein so as to release the central cylindrical stents and proximal flared stent against the sphincter, tumor, and lower esophagus.
  • [0042]
    An in-vitro and in-vivo evaluation of a modified self-expandable metal esophageal stent with an anti-reflux mechanism of the present invention was performed on a number of dogs. The evaluation included four dogs, two of which were males at 14 and 18 kg and two females at 14 and 16 kg. An esophagostomy was utilized with the use of upper gastro-intestinal endoscopy. The evaluation included the methods of ambulatory pH monitoring with the use of Synectics medical equipment at 5 and 10 cm with Gastrograph Inc. software. A liquid diet of Ensure at a pH of 6.5 was administered. The results of the employed methods are included in Table 2.
    TABLE 2
    Standard Stent Anti-Reflux Stent P
    Duration of pH 20.30 ± 1.6 21.38 ± 0.9 ns
    Monitoring (hrs · mins)
    Oral Intake Ensure (ml)  1007 ± 0.5   978 ± 0.4 ns
  • [0043]
    [0043]FIG. 8 depicts in-vitro reflux barrier curve 48 which illustrates the water column height in centimeters necessary to invert a given sleeve length extending from the distal end of the prosthesis. Rectangular median value boxes 49 indicate the median value of the water column height at the indicated sleeve lengths. The vertical bar 50 positioned on curve 48 with rectangular median value boxes 49 represent a standard deviation above and below the indicated median value. In addition, the number of reflux episodes was monitored at the distal and proximal ends of the prosthesis. With a standard prosthesis without a one way valve, 197 episodes of reflux were encountered in 250 attempts. At the proximal end of the standard tubular esphageal prosthesis, a total of 33 reflux episodes were noted with 50 attempts. Correspondently, only 16 reflux episodes were noted out of 250 attempts at the distal end of an anti-reflux esophageal prosthesis of the present invention. At the proximal end of the anti-reflux esophageal stent only 8 episodes out of 50 attempts were noted. The number of reflux episodes longer than five minutes was also noted. In the standard prosthesis, 19.8 episodes were recorded for 25 attempts. This is in contrast to 0.3 episodes for an anti-reflux esophageal stent of the present invention. At the proximal end of the prosthesis, 2.3 episodes lasting longer than five minutes were noted with three attempts; whereas none were noted with the anti-reflux prosthesis. The longest reflux episodes were also noted at the distal and proximal ends of the standard and anti-reflux prosthesis. For the standard prosthesis, 107 episodes were noted out of approximately 130 attempts; whereas only 3.8 were noted for the anti-reflux prosthesis at the distal end thereof. At the proximal end of the prosthesis, 39 episodes were noted out of 45 for the standard prosthesis; whereas only 1.8 for the anti-reflux prosthesis were noted.
  • [0044]
    [0044]FIG. 9 depicts the fraction time percentages of which the esophagus was exposed to gastric juice with a pH less than 4. At the distal end of the prosthesis, the percentage of fraction time is indicated by boxes 51 for the four dogs at the distal end of the standard prosthesis. These percentage fraction times range from 20-80% with a median value of 49%.
  • [0045]
    For the anti-reflux prosthesis, the percentage of fraction time ranges from 0.0 to approximately 1.5% with a median value of 1% as indicated by boxes 52. The p-values for these fractions times is 0.026.
  • [0046]
    [0046]FIG. 10 depicts the fraction time percentages at the proximal ends of the standard and anti-reflux prosthesis. Boxes 53 represent the percent fraction time for the standard prosthesis which ranges from approximately 4-14% with a median of 6.6%. Rectangular boxes 54 represent the percent fraction time for the anti-reflux prosthesis which range from approximately 0.0 to 1.0%. These have a p-value of approximately 0.055.
  • [0047]
    The conclusions resulting from this in-vitro and in-vivo evaluation are as follows. The modified self-expanding metal esophageal stent of the present invention is highly effective in preventing gastro-esophageal reflux. The ability of the modification to invert at higher pressure gradients allows for belching and vomiting. Once inverted, reversion to the anti-reflux position of the prosthesis requires minimal pressure that can be achieved by a water swallow.
  • [0048]
    In a second embodiment of the present invention depicted in FIGS. 11-14, the prosthesis 10 and tubular member 11 comprise a tubular drainage stent 60 having a first end 62 for drainage into a duct, vessel, organ, etc., 30 and a second end 63 that receives the fluid or other material that is moving under a first, antegrade pressure and direction 17. As defined, a tubular drainage stent (or tubular drainage catheter) is typically an elongate, closed tubular conduit (typically plastic or metal) that is placed within a bodily passage, such as the bile duct, pancreatic duct, urethra, etc. to facilitate the flow of fluids therethrough. It is typically non-expanding, unlike a the wire or open-frame stents of FIGS. 1-10. It is commonly placed either to establish or maintain patency of the bodily passage or to drain an organ or fluid source, such as the gall bladder or urinary bladder. The tubular drainage stent may also include a retention means 64,65 at one or more ends 62,63, such as flaps, barbs, pigtail loops, etc. The tubular drainage stent 60 is attached to the collapsible sleeve 13, which acts as a one-way valve to prevent retrograde flow 18 therethrough. The first end 67 of the sleeve is maintained open when the fluid or material passing through the sleeve is exhibiting a pressure associated with normal antegrade flow 17. The first end 67 collapses shut when the antegrade flow 17 has ceased or lessened such that the second fluid pressure 18 occurring in the environment into which the fluid is drained becomes higher than the first pressure of the antegrade flow 17. In the illustrative biliary stent embodiment, bile is able to flow into the duodenum 71, but the sleeve 13 closes in the absence of measurable flow 17, thus preventing the contents of the intestinal tract, which now have a second, higher pressure 18, from entering the passageway of the stent. The sleeve 13 is made of a biocompatible material that will not degrade when placed in the particular environment of the human body into which it is to be placed. Possible materials include expanded polytetrafluoroethylene (ePTFE), polyurethane, silicone, nylon, polyamides such as other urethanes, or other biocompatible materials. It is important that the sleeve material be selected appropriately. For example, in the illustrative embodiment, the sleeve is typically made of a 2-3 cm section of ePTFE which is much more resistant to the caustic bile than would a sleeve of polyurethane. The ePTFE tube is extruded into a thin wall tube having sufficient flexibility to collapse and seal against the ingress of fluid, while having sufficient integrity to resist tearing. The normal range of sleeve thickness for the illustrative embodiment is 0.001 to 0.01 in., with a more preferred thickness of 0.002 to 0.005 in (e.g., 0.0025). The second end 68 of the sleeve is attached about the first end 62 of a biliary stent 60, such as a ST-2 SOEHENDRA TANNENBAUM® stent, a COTTON-LEUNG® stent or a COTTON-HUIBREGTSE® stent (Wilson-Cook Medical Inc., Winston-Salem, N.C.), by an attachment means 66, such as an illustrative crimped metal band. This band 66 can be made radiopaque to also serve as a fluoroscopic marker. Other methods of attachment could include, suture binding, selected medical grade adhesives, or thermal bonding, if appropriate for both the sleeve and stent polymers.
  • [0049]
    An alternative method of forming the sleeve for a tubular drainage stent 60 is depicted in FIG. 12. Rather than attaching a separately extruded or preformed sleeve 13 to the tubular member 11, the wall of the tubular member, which is made of polyethylene in this embodiment, is thinned out distally from the first end 62 of the tubular drainage stent 60, such that the sleeve 13 is integral with the tubular member 11. A transition zone 77 exists between the first end tubular drainage stent 60 and the second end 68 of the sleeve 13, beyond which the sleeve 13 becomes sufficiently thin to collapse into a closed position in the absence of antegrade flow 17, such as bile.
  • [0050]
    [0050]FIG. 13 depicts how the illustrative embodiment is used within the common bile duct 69 to permit the drainage of bile across the Papilla of Vater 70 and into the duodenum 71. The biliary stent 60 is positioned in the normal manner inside the common bile duct 69 with the first end 62 of the stent extending outside of the duct and Papilla of Vater 70. The first retention means 64 abuts the opening of the sphincter to prevent ingress of the stent 60 into the duct while the second retention means 65, located about the second end 63, is positioned well inside the duct to prevent the stent 60 from migrating outward. The sleeve 13 lies completely within the duodenum where it acts as a one-way valve to prevent intestinal contents from entering the biliary stent 60. Unlike the embodiment of FIG. 1, the sleeve 13 is not designed to invert back through the tubular member 13 in the presence of a third, significantly higher pressure, a situation which is normally not found inside the duodenum, or even clinically necessary as with the esophageal embodiment where belching or vomiting make such a capability desirous. Placement of the embodiments of FIGS. 11-12 can be accomplished by a system such as that depicted in FIG. 14. The biliary stent 60 is mounted on a guiding catheter 73 which is fed over an standard biliary exchange wire guide 74 into the bile duct. To deploy the stent from over the guiding catheter 73, a pusher element 72 is used with the distal end 75 of the pusher contacting the first end 62 of stent 60 and urging it forward until deployment occurs. The sleeve 13 is normally folded in accordion fashion prior to deployment, whereby it resumes its elongate configuration once the prosthesis 10 has been properly positioned.
  • [0051]
    [0051]FIG. 15 depicts a prosthesis 10 comprising a tubular drainage stent 60 that is configured for placement in the urinary system, such as within the ureter between the kidney and the bladder. The sleeve 13 is attached to the first end 62 of the tubular drainage stent 60, which includes a first retention means 64 that comprises a pigtail configuration 79. In a ureteral stent, the pigtail 79 would be placed within the bladder to prevent migration of the stent. Optionally, a pigtail configuration 79 can be used to anchor the second end of the stent (not shown), typically within the ureteropelvic junction. The pigtail configuration is exemplary of a large variety of well know pigtail ureteral and urethral stents.
  • [0052]
    [0052]FIG. 16 depicts a tubular drainage stent 60 in which the first end 68 of the sleeve 13 is affixed completely within the lumen 12 of the stent 60, the attachment 66 comprising a well-known means such as thermal bonding, adhesive, or a ring of material that can affix the sleeve 13 material to the inner walls 78 of the stent 60. In the illustrative embodiment, the sleeve 13 resides completely within the lumen 12, such that it doesn't not extend beyond the end of the tubular drainage stent 12. This could have particular utility in a urethral stent to prevent migration of pathogenic organism though the stent and into the bladder, while still allowing antegrade flow of urine 17. Having a sleeve 13 extending out of the urethra would normally be less acceptable from a clinical and patient's point of view.
  • [0053]
    As with each of the embodiments of FIGS. 11-16, it is important that the sleeve be made highly flexible and readily collapsible such that normally exists it a closed state, either by a fluid (air or bodily fluids) applying second pressure in a second direction 18 to at least substantially close the sleeve lumen 15 to greatly reduce retrograde migration of fluids, materials, or pathogens, or merely by the absence of fluid applying a first pressure in a first direction 17. In the preferred embodiments, the sleeve 13 does not maintain its regular tubular configuration (unless perhaps, it is hanging straight down) due to the inability of the thin polymeric material to support such a configuration against gravitational forces. Rather, it collapses into a closed configuration or self-closes to form a one-way valve due to the material adhering to itself, particularly if wet, the atmospheric pressure or fluid pressure in the second direction 18, typically facilitating its closure.
  • [0054]
    It is to be understood that the above described anti-reflux esophageal, biliary, an urological prostheses 10 are merely illustrative embodiments of this invention. The present invention can also include other devices and methods for manufacturing and using them may be devised by those skilled in the art without departing from the spirit and scope of the invention. It is also to be understood that the invention is directed to embodiments both comprising and consisting of disclosed parts. For example, in the esophageal embodiments, it is contemplated that only a portion of the tubular frame need be coated with the sleeve material. Furthermore, the sleeve material extending from the distal end of the tubular member can be formed with different material from that covering the tubular frame. It is also contemplated that the material of the self-expanding stents can be formed of other materials such as nickel titanium alloys commercially known as nitinol, spring steel, and any other spring-like material formed to assume the flexible self-expanding zig-zag stent configuration.

Claims (37)

  1. 1. A prosthesis for placement in a patient comprising:
    a tubular drainage stent having a passage extending longitudinally therethrough; and
    a sleeve extending from an end of the tubular drainage stent and having a lumen extending longitudinally therethrough and communicating with the passage of the tubular drainage stent, the sleeve in response to a fluid applying a first pressure in a first direction passing the fluid through the lumen thereof, the sleeve collapsible to at least substantially close the lumen in response to a fluid applying a second pressure in a second direction.
  2. 2. The prosthesis of claim 1, wherein a portion of the sleeve extends over an outer surface of the tubular drainage stent and is affixed thereto.
  3. 3. The prosthesis of claim 2, wherein the sleeve includes an attachment member that affixes the sleeve to the tubular drainage stent.
  4. 4. The prosthesis of claim 3, wherein the attachment member comprises a metal band.
  5. 5. The prosthesis of claim 1, wherein the sleeve comprises a bile-resistant polymeric material.
  6. 6. The prosthesis of claim 5, wherein the material comprises expanded polytetrafluoroethylene.
  7. 7. The prosthesis of claim 1, wherein the material comprises polyurethane.
  8. 8. The prosthesis of claim 1, wherein the sleeve has an average thickness in the range of approximately 0.001″ to 0.01″.
  9. 9. The prosthesis of claim 8, wherein the sleeve has an average thickness of approximately 0.002″ to 0.005″.
  10. 10. The prosthesis of claim 9, wherein the sleeve has a thickness of approximately 0.0025″.
  11. 11. The prosthesis of claim 1, wherein the tubular drainage stent is sized and configured for placement in the biliary system such that the sleeve is extendable into the intestine of the patient such that bile travels in the first direction thereinto.
  12. 12. The prosthesis of claim 1, wherein the prosthesis further includes a guiding catheter and pusher element having a distal end, the prosthesis being mounted over the guiding catheter such that the prosthesis is deliverable to a target site within the patient by way of the distal end of the pusher element urging the prosthesis distally and relative to the guiding catheter until the prosthesis is deployed therefrom.
  13. 13. The prosthesis of claim 1, wherein the sleeve and tubular drainage stent comprise the same polymeric material, the sleeve representing an integral extension of the one end of the tubular drainage stent.
  14. 14. The prosthesis of claim 1, wherein the sleeve is normally closed in the absence of the fluid applying a first pressure in a first direction.
  15. 15. The prosthesis of claim 1, wherein the end form which the sleeve extends includes a pigtail configuration.
  16. 16. A prosthesis for placement in a patient comprising:
    a tubular drainage stent sized and configured for placement in the biliary system, the tubular drainage stent having a passage extending longitudinally therethrough; and
    a sleeve comprising a polymeric material, the sleeve extending from an end of the tubular drainage stent and having a lumen extending longitudinally therethrough and communicating with the passage of the tubular drainage stent, the sleeve in response to a fluid applying a first pressure in a first direction passing the fluid through the lumen thereof, the sleeve collapsible to at least substantially close the lumen in response to a fluid applying a second pressure in a second direction.
  17. 17. The prosthesis of claim 16, wherein the sleeve is normally closed in the absence of the fluid applying a first pressure in a first direction.
  18. 18. The prosthesis of claim 16, wherein the material comprises expanded polytetrafluoroethylene.
  19. 19. The prosthesis of claim 16, wherein the sleeve has an average thickness of approximately 0.002″ to 0.005″.
  20. 20. The prosthesis of claim 14, wherein the prosthesis further includes a guiding catheter and pusher element having a distal end, the prosthesis being mounted over the guiding catheter such that the prosthesis is deliverable to a target site within the patient by way of the distal end of the pusher element urging the prosthesis distally and relative to the guiding catheter until the prosthesis is deployed therefrom.
  21. 21. A prosthesis for placement in a patient comprising:
    a tubular drainage stent sized and configured for placement in a bodily passageway, the tubular drainage stent having a passage extending longitudinally therethrough, and
    a sleeve comprising a thin, flexible polymeric material, the sleeve attached about the tubular drainage stent and having a lumen extending longitudinally therethrough and communicating with the passage of the tubular drainage stent, the sleeve in response to a fluid applying a first pressure in a first direction passing the fluid through the lumen thereof, the sleeve collapsible to at least substantially close the lumen in response to either a fluid applying a second pressure in a second direction or the absence of the fluid applying a first pressure in a first direction.
  22. 22. The prosthesis of claim 21, wherein the sleeve extends from an end of the tubular drainage stent.
  23. 23. The prosthesis of claim 21, wherein one end of the sleeve is affixed within the lumen of the tubular drainage stent.
  24. 24. The prosthesis of claim 21, wherein the sleeve resides completely within the lumen of the tubular drainage stent.
  25. 25. (Cancelled)
  26. 26. (Cancelled)
  27. 27. (Cancelled)
  28. 28. A prosthesis for placement in a patient comprising:
    a tubular drainage stent having a passage extending longitudinally there through configured to pass only bodily matter;
    a retention structure extending from an outer surface of the passage and comprising a flexible material configured to hold the tubular drainage stent within a vessel that conveys fluid without enlarging a diameter of the passage; and
    a sleeve extending from an end of the tubular drainage stent and having a lumen extending longitudinally there through and communicating with the passage of the tubular drainage stent, the sleeve in response to a fluid applying a first pressure in a first direction passing the fluid through the lumen thereof, the sleeve collapsible to at least substantially close the lumen in response to a fluid applying a second pressure in a second direction.
  29. 29. The prosthesis of claim 28, wherein the retention structure comprises a structure selected from the group consisting of a flap and a barb.
  30. 30. The prosthesis of claim 28, wherein the tubular drainage stent is sized and configured for placement within a body passage selected from the group consisting essentially of a bile duct, a pancreatic duct, and a urethra.
  31. 31. The prosthesis of claim 28, wherein the tubular drainage stent is sized and configured for placement within a body passage selected from the group consisting of a pancreatic duct and a urethra.
  32. 32. (Cancelled)
  33. 33. (Cancelled)
  34. 34. A prosthesis for placement in a patient comprising:
    a tubular drainage stent having a passage sized and configured for placement within a pancreatic duct;
    a retention structure extending from an outer surface of the passage comprising a flexible material configured to expand without enlarging a diameter of the passage; and
    a sleeve extending from an end of the tubular drainage stent and having a lumen extending longitudinally there through and communicating with the passage of the tubular drainage stent, the sleeve in response to a fluid applying a first pressure in a first direction passing the fluid through the lumen thereof, the sleeve collapsible to at least substantially close the lumen in response to a fluid applying a second pressure in a second direction.
  35. 35. A prosthesis for placement in a patient comprising:
    a tubular drainage stent having a passage sized and configured for placement within a urethra;
    a retention structure extending from an outer surface of the passage comprising a flexible material configured to expand without enlarging a diameter of the passage; and
    a sleeve extending from an end of the tubular drainage stent and having a lumen extending longitudinally there through and communicating with the passage of the tubular drainage stent, the sleeve in response to a fluid applying a first pressure in a first direction passing the fluid through the lumen thereof, the sleeve collapsible to at least substantially close the lumen in response to a fluid applying a second pressure in a second direction.
  36. 36. A prosthesis for placement in a patient comprising:
    a tubular drainage stent having a passage sized and configured for conveying a glandular secretion;
    a retention structure extending from an outer surface of the passage comprising a flexible material configured to expand without enlarging a diameter of the passage; and
    a sleeve extending from an end of the tubular drainage stent and having a lumen extending longitudinally there through and communicating with the passage of the tubular drainage stent, the sleeve in response to a fluid applying a first pressure in a first direction passing the fluid through the lumen thereof, the sleeve collapsible to at least substantially close the lumen in response to a fluid applying a second pressure in a second direction.
  37. 37. A prosthesis for placement in a patient comprising:
    a non-expanding tubular drainage stent sized and configured for placement in a bodily passageway, the tubular drainage stent having a passage extending longitudinally there through, and
    a sleeve comprising a thin, flexible polymeric material, the sleeve attached about the tubular drainage stent and having a lumen extending longitudinally there through and communicating with the passage of the tubular drainage stent, the sleeve in response to a fluid applying a first pressure in a first direction passing the fluid through the lumen thereof, the sleeve collapsible to at least substantially close the lumen in response to either a fluid applying a second pressure in a second direction or the absence of the fluid applying a first pressure in a first direction.
US10827957 1998-08-31 2004-04-20 Prosthesis having a sleeve valve Abandoned US20040199262A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US9854298 true 1998-08-31 1998-08-31
US09386173 US6302917B1 (en) 1998-08-31 1999-08-31 Anti-reflux esophageal prosthesis
US21175300 true 2000-06-14 2000-06-14
US09876520 US6746489B2 (en) 1998-08-31 2001-06-07 Prosthesis having a sleeve valve
US10827957 US20040199262A1 (en) 1998-08-31 2004-04-20 Prosthesis having a sleeve valve

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10827957 US20040199262A1 (en) 1998-08-31 2004-04-20 Prosthesis having a sleeve valve

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US09386173 Continuation-In-Part US6302917B1 (en) 1998-08-31 1999-08-31 Anti-reflux esophageal prosthesis
US09876520 Continuation US6746489B2 (en) 1998-08-31 2001-06-07 Prosthesis having a sleeve valve

Publications (1)

Publication Number Publication Date
US20040199262A1 true true US20040199262A1 (en) 2004-10-07

Family

ID=27378622

Family Applications (2)

Application Number Title Priority Date Filing Date
US09876520 Active US6746489B2 (en) 1998-08-31 2001-06-07 Prosthesis having a sleeve valve
US10827957 Abandoned US20040199262A1 (en) 1998-08-31 2004-04-20 Prosthesis having a sleeve valve

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09876520 Active US6746489B2 (en) 1998-08-31 2001-06-07 Prosthesis having a sleeve valve

Country Status (1)

Country Link
US (2) US6746489B2 (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006083763A1 (en) * 2005-01-31 2006-08-10 Wilson-Cook Medical Inc. Prosthesis having a sleeve valve
US20070198048A1 (en) * 2005-12-23 2007-08-23 Niall Behan Medical device suitable for treating reflux from a stomach to an oesophagus
US20070282452A1 (en) * 2006-05-30 2007-12-06 Boston Scientific Scimed, Inc. Anti-obesity dual stent
WO2008103572A1 (en) * 2007-02-22 2008-08-28 Wilson-Cook Medical Inc. Prosthesis having a sleeve valve
US20090143759A1 (en) * 2007-11-30 2009-06-04 Jacques Van Dam Methods, Devices, Kits and Systems for Defunctionalizing the Cystic Duct
US20100114327A1 (en) * 2008-06-20 2010-05-06 Vysera Biomedical Limited Valve
US20110054381A1 (en) * 2009-05-29 2011-03-03 Jacques Van Dam Biliary shunts, delivery systems, and methods of using the same
US20110160836A1 (en) * 2008-06-20 2011-06-30 Vysera Biomedical Limited Valve device
US8029557B2 (en) 2008-06-20 2011-10-04 Vysera Biomedical Limited Esophageal valve
US8211186B2 (en) 2009-04-03 2012-07-03 Metamodix, Inc. Modular gastrointestinal prostheses
US8282598B2 (en) 2009-07-10 2012-10-09 Metamodix, Inc. External anchoring configurations for modular gastrointestinal prostheses
US8702641B2 (en) 2009-04-03 2014-04-22 Metamodix, Inc. Gastrointestinal prostheses having partial bypass configurations
US8876800B2 (en) 2009-12-18 2014-11-04 Vysera Biomedical Limited Urological device
US8992410B2 (en) 2010-11-03 2015-03-31 Vysera Biomedical Limited Urological device
US9173760B2 (en) 2009-04-03 2015-11-03 Metamodix, Inc. Delivery devices and methods for gastrointestinal implants
US9278019B2 (en) 2009-04-03 2016-03-08 Metamodix, Inc Anchors and methods for intestinal bypass sleeves
US20160128824A1 (en) * 2013-07-11 2016-05-12 Olympus Corporation Stent
US9622897B1 (en) 2016-03-03 2017-04-18 Metamodix, Inc. Pyloric anchors and methods for intestinal bypass sleeves

Families Citing this family (124)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070016306A1 (en) * 1998-08-31 2007-01-18 Wilson-Cook Medical Inc. Prosthesis having a sleeve valve
US20080086214A1 (en) * 1998-08-31 2008-04-10 Wilson-Cook Medical Inc. Medical device having a sleeve valve with bioactive agent
US7033373B2 (en) * 2000-11-03 2006-04-25 Satiety, Inc. Method and device for use in minimally invasive placement of space-occupying intragastric devices
US6620122B2 (en) * 2001-04-26 2003-09-16 Scimed Life Systems, Inc. Gastric pseudocyst drainage and stent delivery system for use therein
US6558400B2 (en) 2001-05-30 2003-05-06 Satiety, Inc. Obesity treatment tools and methods
CN101810521B (en) * 2001-08-27 2015-05-13 辛尼科有限责任公司 Satiation devices and methods
US6913625B2 (en) * 2002-03-07 2005-07-05 Scimed Life Systems, Inc. Ureteral stent
US6746460B2 (en) 2002-08-07 2004-06-08 Satiety, Inc. Intra-gastric fastening devices
US7214233B2 (en) 2002-08-30 2007-05-08 Satiety, Inc. Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach
US7033384B2 (en) 2002-08-30 2006-04-25 Satiety, Inc. Stented anchoring of gastric space-occupying devices
US7220237B2 (en) 2002-10-23 2007-05-22 Satiety, Inc. Method and device for use in endoscopic organ procedures
US7794447B2 (en) 2002-11-01 2010-09-14 Valentx, Inc. Gastrointestinal sleeve device and methods for treatment of morbid obesity
US7037344B2 (en) * 2002-11-01 2006-05-02 Valentx, Inc. Apparatus and methods for treatment of morbid obesity
EP1750595A4 (en) 2004-05-07 2008-10-22 Valentx Inc Devices and methods for attaching an endolumenal gastrointestinal implant
US9060844B2 (en) * 2002-11-01 2015-06-23 Valentx, Inc. Apparatus and methods for treatment of morbid obesity
US20090149871A9 (en) * 2002-11-01 2009-06-11 Jonathan Kagan Devices and methods for treating morbid obesity
US7837669B2 (en) 2002-11-01 2010-11-23 Valentx, Inc. Devices and methods for endolumenal gastrointestinal bypass
US20040102855A1 (en) * 2002-11-21 2004-05-27 Scimed Life Systems, Inc. Anti-reflux stent
DE10255344A1 (en) * 2002-11-27 2005-06-30 Siemens Ag A conveyor system for cargo, in particular containers for luggage, and control method for the conveyor system
US7695446B2 (en) * 2002-12-02 2010-04-13 Gi Dynamics, Inc. Methods of treatment using a bariatric sleeve
US7025791B2 (en) * 2002-12-02 2006-04-11 Gi Dynamics, Inc. Bariatric sleeve
US7678068B2 (en) * 2002-12-02 2010-03-16 Gi Dynamics, Inc. Atraumatic delivery devices
US20070032879A1 (en) * 2002-12-02 2007-02-08 Levine Andy H Anti-buckling sleeve
CA2512203C (en) 2002-12-02 2012-10-23 Gi Dynamics, Inc. Bariatric sleeve
US7608114B2 (en) * 2002-12-02 2009-10-27 Gi Dynamics, Inc. Bariatric sleeve
US20040143342A1 (en) * 2003-01-16 2004-07-22 Stack Richard S. Satiation pouches and methods of use
US7357818B2 (en) 2003-03-26 2008-04-15 Boston Scientific Scimed, Inc. Self-retaining stent
US20040220682A1 (en) * 2003-03-28 2004-11-04 Gi Dynamics, Inc. Anti-obesity devices
EP1610719B1 (en) * 2003-03-28 2010-01-13 GI Dynamics, Inc. Sleeve for delayed introduction of enzymes into the intestine
US7175638B2 (en) 2003-04-16 2007-02-13 Satiety, Inc. Method and devices for modifying the function of a body organ
WO2005011534A1 (en) * 2003-07-31 2005-02-10 Cook Incorporated Prosthetic valve devices and methods of making such devices
EP1660164B1 (en) * 2003-07-31 2009-04-29 Wilson-Cook Medical Inc. System for introducing multiple medical devices
US7314489B2 (en) * 2003-08-20 2008-01-01 Ethicon Endo-Surgery, Inc. Method and apparatus to facilitate nutritional malabsorption
US8206456B2 (en) 2003-10-10 2012-06-26 Barosense, Inc. Restrictive and/or obstructive implant system for inducing weight loss
US7914543B2 (en) 2003-10-14 2011-03-29 Satiety, Inc. Single fold device for tissue fixation
US7097650B2 (en) 2003-10-14 2006-08-29 Satiety, Inc. System for tissue approximation and fixation
US20050085787A1 (en) * 2003-10-17 2005-04-21 Laufer Michael D. Minimally invasive gastrointestinal bypass
US8057420B2 (en) 2003-12-09 2011-11-15 Gi Dynamics, Inc. Gastrointestinal implant with drawstring
EP1708641A1 (en) 2003-12-09 2006-10-11 GI Dynamics, Inc. Intestinal sleeve
US20050177176A1 (en) 2004-02-05 2005-08-11 Craig Gerbi Single-fold system for tissue approximation and fixation
EP1713402A2 (en) 2004-02-13 2006-10-25 Satiety, Inc. Methods for reducing stomach volume
WO2005084592A2 (en) 2004-02-27 2005-09-15 Satiety, Inc. Methods and devices for reducing hollow organ volume
US8449560B2 (en) 2004-03-09 2013-05-28 Satiety, Inc. Devices and methods for placement of partitions within a hollow body organ
US9028511B2 (en) 2004-03-09 2015-05-12 Ethicon Endo-Surgery, Inc. Devices and methods for placement of partitions within a hollow body organ
US8252009B2 (en) 2004-03-09 2012-08-28 Ethicon Endo-Surgery, Inc. Devices and methods for placement of partitions within a hollow body organ
US8628547B2 (en) 2004-03-09 2014-01-14 Ethicon Endo-Surgery, Inc. Devices and methods for placement of partitions within a hollow body organ
EP1750627A2 (en) 2004-03-26 2007-02-14 Satiety, Inc. Systems and methods for treating obesity
US20050228413A1 (en) * 2004-04-12 2005-10-13 Binmoeller Kenneth F Automated transluminal tissue targeting and anchoring devices and methods
US8425539B2 (en) 2004-04-12 2013-04-23 Xlumena, Inc. Luminal structure anchoring devices and methods
WO2005120363A8 (en) * 2004-06-03 2007-09-07 Mayo Foundation Obesity treatment and device
EP1768618B1 (en) * 2004-07-09 2011-04-20 GI Dynamics, Inc. Devices for placing a gastrointestinal sleeve
US20060020277A1 (en) * 2004-07-20 2006-01-26 Gostout Christopher J Gastric reshaping devices and methods
US8123762B2 (en) 2004-08-19 2012-02-28 Boston Scientific Scimed, Inc. Suturing instrument
EP1799145B1 (en) * 2004-09-17 2016-12-21 GI Dynamics, Inc. Gastrointestinal anchor
ES2582334T3 (en) 2004-10-15 2016-09-12 Bfkw, Llc bariatric device
US20060106288A1 (en) 2004-11-17 2006-05-18 Roth Alex T Remote tissue retraction device
US7451765B2 (en) * 2004-11-18 2008-11-18 Mark Adler Intra-bronchial apparatus for aspiration and insufflation of lung regions distal to placement or cross communication and deployment and placement system therefor
US7666133B2 (en) * 2004-12-06 2010-02-23 Sam Drager Apparatus and method for correcting urinary incontinence
EP1858396A4 (en) 2004-12-08 2015-11-25 Inc Xlumena Method and apparatus for performing needle guided interventions
US7766973B2 (en) * 2005-01-19 2010-08-03 Gi Dynamics, Inc. Eversion resistant sleeves
US7771382B2 (en) * 2005-01-19 2010-08-10 Gi Dynamics, Inc. Resistive anti-obesity devices
US20060173525A1 (en) * 2005-02-02 2006-08-03 Percutaneous Systems, Inc. Methods and systems for deploying luminal prostheses
US20060212042A1 (en) * 2005-03-17 2006-09-21 Lamport Ronald B Removal and repositioning device
KR100691503B1 (en) 2005-03-21 2007-03-09 (주) 태웅메디칼 A stent for the gullet
DE102005016103B4 (en) * 2005-04-08 2014-10-09 Merit Medical Systems, Inc. Duodenumstent
DE102005019649A1 (en) * 2005-04-26 2006-11-02 Alveolus Inc. Flexible stent for positioning in lumen of esophagus comprises tube and stabilization members defined circumferentially about tube, where each member extends inwardly in tube to define inner diameter that is less than inner diameter of tube
US7396366B2 (en) 2005-05-11 2008-07-08 Boston Scientific Scimed, Inc. Ureteral stent with conforming retention structure
US7976488B2 (en) 2005-06-08 2011-07-12 Gi Dynamics, Inc. Gastrointestinal anchor compliance
US8777967B2 (en) 2005-06-09 2014-07-15 Xlumena, Inc. Methods and devices for anchoring to tissue
US8784437B2 (en) 2005-06-09 2014-07-22 Xlumena, Inc. Methods and devices for endosonography-guided fundoplexy
US7550012B2 (en) * 2005-08-31 2009-06-23 Cook Ireland Limited Stent for implantation
ES2368589T3 (en) * 2005-08-31 2011-11-18 Cook Medical Technologies Llc Catheter for stenting.
US7789915B2 (en) * 2005-08-31 2010-09-07 Vance Products Incorporated Stent for implantation
US8084154B2 (en) * 2007-02-08 2011-12-27 Karl Frederick Scheucher Battery pack safety and thermal management apparatus and method
US8376981B2 (en) 2006-03-02 2013-02-19 Michael D. Laufer Gastrointestinal implant and methods for use
US7881797B2 (en) 2006-04-25 2011-02-01 Valentx, Inc. Methods and devices for gastrointestinal stimulation
CA2659735C (en) * 2006-06-22 2012-01-24 Wilson-Cook Medical Inc. Self-cleaning stent
US7819836B2 (en) * 2006-06-23 2010-10-26 Gi Dynamics, Inc. Resistive anti-obesity devices
US20080027415A1 (en) * 2006-07-28 2008-01-31 Becton, Dickinson And Company Vascular access device volume displacement
US20080051911A1 (en) * 2006-08-23 2008-02-28 Wilson-Cook Medical Inc. Stent with antimicrobial drainage lumen surface
WO2008039800A3 (en) 2006-09-25 2008-07-17 Valentx Inc Toposcopic access and delivery devices
CA2665868C (en) * 2006-10-16 2013-08-06 Wilson-Cook Medical Inc. Nonexpandable stent
WO2008079476A3 (en) * 2006-12-21 2009-05-14 George Y Choi Eustachian tube treatment systems
US8529431B2 (en) 2007-02-14 2013-09-10 Bfkw, Llc Bariatric device and method
WO2008100984A3 (en) * 2007-02-14 2008-10-16 Sentinel Group Llc Mucosal capture fixation of medical device
US8801647B2 (en) * 2007-02-22 2014-08-12 Gi Dynamics, Inc. Use of a gastrointestinal sleeve to treat bariatric surgery fistulas and leaks
US8114045B2 (en) * 2007-03-02 2012-02-14 Cook Medical Technologies Llc Apparatus and methods for delaying gastric emptying to treat obesity
WO2008154450A1 (en) 2007-06-08 2008-12-18 Valentx, Inc. Methods and devices for intragastric support of functional or prosthetic gastrointestinal devices
US20090138093A1 (en) * 2007-11-27 2009-05-28 Minos Medical System and method for esophageal sphincter repair
US8574284B2 (en) 2007-12-26 2013-11-05 Cook Medical Technologies Llc Low profile non-symmetrical bare alignment stents with graft
US9226813B2 (en) 2007-12-26 2016-01-05 Cook Medical Technologies Llc Low profile non-symmetrical stent
US9757263B2 (en) 2009-11-18 2017-09-12 Cook Medical Technologies Llc Stent graft and introducer assembly
US9180030B2 (en) 2007-12-26 2015-11-10 Cook Medical Technologies Llc Low profile non-symmetrical stent
WO2009100313A1 (en) * 2008-02-06 2009-08-13 The Trustees Of The University Of Pennsylvania Device for preventing gastro-esophageal reflux
US20090259286A1 (en) * 2008-04-14 2009-10-15 Cappella, Inc. Sheath With Radio-Opaque Markers For Identifying Split Propagation
US8454632B2 (en) * 2008-05-12 2013-06-04 Xlumena, Inc. Tissue anchor for securing tissue layers
US20090312645A1 (en) * 2008-06-16 2009-12-17 Boston Scientific Scimed, Inc. Methods and Devices for Accessing Anatomic Structures
WO2010011878A3 (en) * 2008-07-24 2010-03-25 Cook Incorporated Valve device with biased leaflets
WO2010021743A1 (en) * 2008-08-21 2010-02-25 Sentinel Group, Llc Gastro-esophageal device and method
CA2752905A1 (en) * 2009-04-02 2010-10-07 Cook Medical Technologies Llc System and method for maintaining patency of a stent using a magnet
US9364259B2 (en) 2009-04-21 2016-06-14 Xlumena, Inc. System and method for delivering expanding trocar through a sheath
US8357193B2 (en) 2009-05-29 2013-01-22 Xlumena, Inc. Apparatus and method for deploying stent across adjacent tissue layers
US9211182B2 (en) 2009-11-20 2015-12-15 E2, Llc Anti-reflux devices and methods for treating gastro-esophageal reflux disease (GERD)
GB2475494B (en) * 2009-11-18 2011-11-23 Cook William Europ Stent graft and introducer assembly
GB0920327D0 (en) 2009-11-19 2010-01-06 Cook William Europ Stent graft
EP3153135A1 (en) * 2009-12-18 2017-04-12 Coloplast A/S A gastrointestinal implant device
WO2012007050A1 (en) * 2010-07-16 2012-01-19 Ethicon Endo-Surgery, Inc. System and method for modifying the location at which biliopancreatic secretions interact with the gastrointestinal tract
CN103619281B (en) 2011-05-20 2016-02-24 Bfkw有限公司 Intraluminal device having enhanced anti-migration
JP6179949B2 (en) * 2012-01-30 2017-08-16 川澄化学工業株式会社 Biliary stent
US20130231752A1 (en) * 2012-03-02 2013-09-05 Cook Medical Technologies Llc Endoluminal prosthesis with actuating member
WO2013134227A1 (en) 2012-03-06 2013-09-12 Bfkw, Llc Intraluminal device delivery technique
US9314325B2 (en) 2012-04-27 2016-04-19 Cook Medical Technologies Llc Anti-aspiration prosthesis
US9427303B2 (en) 2012-04-27 2016-08-30 Cook Medical Technologies Llc Anti-aspiration valve
EP2854654A4 (en) 2012-05-17 2016-03-16 Xlumena Inc Methods and devices for access across adjacent tissue layers
US9451960B2 (en) 2012-05-31 2016-09-27 Valentx, Inc. Devices and methods for gastrointestinal bypass
US9050168B2 (en) 2012-05-31 2015-06-09 Valentx, Inc. Devices and methods for gastrointestinal bypass
US9681975B2 (en) 2012-05-31 2017-06-20 Valentx, Inc. Devices and methods for gastrointestinal bypass
EP2874568B1 (en) 2012-07-20 2018-01-10 Cook Medical Technologies LLC Implantable medical device having a sleeve
EP2911611A1 (en) 2012-10-24 2015-09-02 Cook Medical Technologies LLC Anti-reflux prosthesis
US9498356B2 (en) 2012-12-19 2016-11-22 Cook Medical Technologies, LLC Flexible stent and delivery system
EP2752170B1 (en) 2013-01-08 2017-02-22 Cook Medical Technologies LLC Multi valve anti-reflux prosthesis
US9757264B2 (en) 2013-03-13 2017-09-12 Valentx, Inc. Devices and methods for gastrointestinal bypass
US9763814B2 (en) 2014-10-24 2017-09-19 Cook Medical Technologies Llc Elongate medical device
WO2017044929A1 (en) * 2015-09-11 2017-03-16 Parker-Haniifin Corporation Endoscopically deployable anti-reflux device

Citations (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868956A (en) * 1972-06-05 1975-03-04 Ralph J Alfidi Vessel implantable appliance and method of implanting it
US3890977A (en) * 1974-03-01 1975-06-24 Bruce C Wilson Kinetic memory electrodes, catheters and cannulae
US4149911A (en) * 1977-01-24 1979-04-17 Raychem Limited Memory metal article
US4271827A (en) * 1979-09-13 1981-06-09 Angelchik Jean P Method for prevention of gastro esophageal reflux
US4425908A (en) * 1981-10-22 1984-01-17 Beth Israel Hospital Blood clot filter
US4445896A (en) * 1982-03-18 1984-05-01 Cook, Inc. Catheter plug
US4494531A (en) * 1982-12-06 1985-01-22 Cook, Incorporated Expandable blood clot filter
US4503569A (en) * 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US4512338A (en) * 1983-01-25 1985-04-23 Balko Alexander B Process for restoring patency to body vessels
US4572186A (en) * 1983-12-07 1986-02-25 Cordis Corporation Vessel dilation
US4580568A (en) * 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4636313A (en) * 1984-02-03 1987-01-13 Vaillancourt Vincent L Flexible filter disposed within flexible conductor
US4649922A (en) * 1986-01-23 1987-03-17 Wiktor Donimik M Catheter arrangement having a variable diameter tip and spring prosthesis
US4655771A (en) * 1982-04-30 1987-04-07 Shepherd Patents S.A. Prosthesis comprising an expansible or contractile tubular body
US4657530A (en) * 1984-04-09 1987-04-14 Henry Buchwald Compression pump-catheter
US4665918A (en) * 1986-01-06 1987-05-19 Garza Gilbert A Prosthesis system and method
US4681110A (en) * 1985-12-02 1987-07-21 Wiktor Dominik M Catheter arrangement having a blood vessel liner, and method of using it
US4687468A (en) * 1984-10-01 1987-08-18 Cook, Incorporated Implantable insulin administration device
US4716900A (en) * 1986-05-09 1988-01-05 Pfizer Hospital Products Group, Inc. Intraintestinal bypass graft
US4719916A (en) * 1983-10-03 1988-01-19 Biagio Ravo Intraintestinal bypass tube
US4723549A (en) * 1986-09-18 1988-02-09 Wholey Mark H Method and apparatus for dilating blood vessels
US4729766A (en) * 1980-08-28 1988-03-08 Astra Meditec Aktiebolag Vascular prosthesis and method in producing it
US4732152A (en) * 1984-12-05 1988-03-22 Medinvent S.A. Device for implantation and a method of implantation in a vessel using such device
US4733665A (en) * 1985-11-07 1988-03-29 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4762128A (en) * 1986-12-09 1988-08-09 Advanced Surgical Intervention, Inc. Method and apparatus for treating hypertrophy of the prostate gland
US4768507A (en) * 1986-02-24 1988-09-06 Medinnovations, Inc. Intravascular stent and percutaneous insertion catheter system for the dilation of an arterial stenosis and the prevention of arterial restenosis
US4794928A (en) * 1987-06-10 1989-01-03 Kletschka Harold D Angioplasty device and method of using the same
US4800882A (en) * 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US4820298A (en) * 1987-11-20 1989-04-11 Leveen Eric G Internal vascular prosthesis
US4825861A (en) * 1985-05-04 1989-05-02 Walter Koss Of Industriestrasse Endotube
US4830003A (en) * 1988-06-17 1989-05-16 Wolff Rodney G Compressive stent and delivery system
US4846836A (en) * 1988-10-03 1989-07-11 Reich Jonathan D Artificial lower gastrointestinal valve
US4848343A (en) * 1986-10-31 1989-07-18 Medinvent S.A. Device for transluminal implantation
US4856516A (en) * 1989-01-09 1989-08-15 Cordis Corporation Endovascular stent apparatus and method
US4907336A (en) * 1987-03-13 1990-03-13 Cook Incorporated Method of making an endovascular stent and delivery system
US4913141A (en) * 1988-10-25 1990-04-03 Cordis Corporation Apparatus and method for placement of a stent within a subject vessel
US4921484A (en) * 1988-07-25 1990-05-01 Cordis Corporation Mesh balloon catheter device
US4922905A (en) * 1985-11-30 1990-05-08 Strecker Ernst P Dilatation catheter
US4955899A (en) * 1989-05-26 1990-09-11 Impra, Inc. Longitudinally compliant vascular graft
US4957508A (en) * 1986-10-31 1990-09-18 Ube Industries, Ltd. Medical tubes
US5015253A (en) * 1989-06-15 1991-05-14 Cordis Corporation Non-woven endoprosthesis
US5019102A (en) * 1987-12-10 1991-05-28 Eberhard Hoene Anti-refluxive internal ureteral stent with a dynamic hood-valve at the vesical end for prevention of urinary reflux into the upper urinary tract upon increase of vesical pressure
US5019090A (en) * 1988-09-01 1991-05-28 Corvita Corporation Radially expandable endoprosthesis and the like
US5026377A (en) * 1989-07-13 1991-06-25 American Medical Systems, Inc. Stent placement instrument and method
US5035706A (en) * 1989-10-17 1991-07-30 Cook Incorporated Percutaneous stent and method for retrieval thereof
US5041126A (en) * 1987-03-13 1991-08-20 Cook Incorporated Endovascular stent and delivery system
US5078736A (en) * 1990-05-04 1992-01-07 Interventional Thermodynamics, Inc. Method and apparatus for maintaining patency in the body passages
US5089006A (en) * 1989-11-29 1992-02-18 Stiles Frank B Biological duct liner and installation catheter
US5108416A (en) * 1990-02-13 1992-04-28 C. R. Bard, Inc. Stent introducer system
US5112900A (en) * 1990-11-28 1992-05-12 Tactyl Technologies, Inc. Elastomeric triblock copolymer compositions and articles made therewith
US5123917A (en) * 1990-04-27 1992-06-23 Lee Peter Y Expandable intraluminal vascular graft
US5133732A (en) * 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US5135536A (en) * 1991-02-05 1992-08-04 Cordis Corporation Endovascular stent and method
US5176626A (en) * 1992-01-15 1993-01-05 Wilson-Cook Medical, Inc. Indwelling stent
US5221261A (en) * 1990-04-12 1993-06-22 Schneider (Usa) Inc. Radially expandable fixation member
US5282823A (en) * 1992-03-19 1994-02-01 Medtronic, Inc. Intravascular radially expandable stent
US5282824A (en) * 1990-10-09 1994-02-01 Cook, Incorporated Percutaneous stent assembly
US5306300A (en) * 1992-09-22 1994-04-26 Berry H Lee Tubular digestive screen
US5314473A (en) * 1989-07-20 1994-05-24 Godin Norman J Prosthesis for preventing gastric reflux into the esophagus
US5316543A (en) * 1990-11-27 1994-05-31 Cook Incorporated Medical apparatus and methods for treating sliding hiatal hernias
US5316023A (en) * 1992-01-08 1994-05-31 Expandable Grafts Partnership Method for bilateral intra-aortic bypass
US5330500A (en) * 1990-10-18 1994-07-19 Song Ho Y Self-expanding endovascular stent with silicone coating
US5334210A (en) * 1993-04-09 1994-08-02 Cook Incorporated Vascular occlusion assembly
US5405316A (en) * 1993-11-17 1995-04-11 Magram; Gary Cerebrospinal fluid shunt
US5405377A (en) * 1992-02-21 1995-04-11 Endotech Ltd. Intraluminal stent
US5411552A (en) * 1990-05-18 1995-05-02 Andersen; Henning R. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
US5413601A (en) * 1990-03-26 1995-05-09 Keshelava; Viktor V. Tubular organ prosthesis
US5443499A (en) * 1993-01-14 1995-08-22 Meadox Medicals, Inc. Radially expandable tubular prosthesis
US5500014A (en) * 1989-05-31 1996-03-19 Baxter International Inc. Biological valvular prothesis
US5507771A (en) * 1992-06-15 1996-04-16 Cook Incorporated Stent assembly
US5534287A (en) * 1993-04-23 1996-07-09 Schneider (Europe) A.G. Methods for applying an elastic coating layer on stents
US5545211A (en) * 1993-09-27 1996-08-13 Sooho Medi-Tech Co., Ltd. Stent for expanding a lumen
US5645559A (en) * 1992-05-08 1997-07-08 Schneider (Usa) Inc Multiple layer stent
US5647843A (en) * 1996-05-24 1997-07-15 Vance Products Incorporated Anti-reflux ureteral stent
US5662713A (en) * 1991-10-09 1997-09-02 Boston Scientific Corporation Medical stents for body lumens exhibiting peristaltic motion
US5665115A (en) * 1992-02-21 1997-09-09 Boston Scientific Technology, Inc. Intraluminal stent
US5716393A (en) * 1994-05-26 1998-02-10 Angiomed Gmbh & Co. Medizintechnik Kg Stent with an end of greater diameter than its main body
US5733325A (en) * 1993-11-04 1998-03-31 C. R. Bard, Inc. Non-migrating vascular prosthesis and minimally invasive placement system
US5733330A (en) * 1997-01-13 1998-03-31 Advanced Cardiovascular Systems, Inc. Balloon-expandable, crush-resistant locking stent
US5741333A (en) * 1995-04-12 1998-04-21 Corvita Corporation Self-expanding stent for a medical device to be introduced into a cavity of a body
US5746766A (en) * 1995-05-09 1998-05-05 Edoga; John K. Surgical stent
US5755769A (en) * 1992-03-12 1998-05-26 Laboratoire Perouse Implant Expansible endoprosthesis for a human or animal tubular organ, and fitting tool for use thereof
US5782904A (en) * 1993-09-30 1998-07-21 Endogad Research Pty Limited Intraluminal graft
US5788626A (en) * 1995-11-21 1998-08-04 Schneider (Usa) Inc Method of making a stent-graft covered with expanded polytetrafluoroethylene
US5861036A (en) * 1995-03-28 1999-01-19 Biomedix S.A. Switzerland Medical prosthesis for preventing gastric reflux in the esophagus
US5876445A (en) * 1991-10-09 1999-03-02 Boston Scientific Corporation Medical stents for body lumens exhibiting peristaltic motion
US5876450A (en) * 1997-05-09 1999-03-02 Johlin, Jr.; Frederick C. Stent for draining the pancreatic and biliary ducts and instrumentation for the placement thereof
US5879382A (en) * 1989-08-24 1999-03-09 Boneau; Michael D. Endovascular support device and method
US5922019A (en) * 1995-11-27 1999-07-13 Schneider (Europe) A.G. Conical stent
US6010529A (en) * 1996-12-03 2000-01-04 Atrium Medical Corporation Expandable shielded vessel support
US6027525A (en) * 1996-05-23 2000-02-22 Samsung Electronics., Ltd. Flexible self-expandable stent and method for making the same
US6264700B1 (en) * 1998-08-27 2001-07-24 Endonetics, Inc. Prosthetic gastroesophageal valve

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1576374A (en) 1968-01-29 1969-08-01
US3996938A (en) 1975-07-10 1976-12-14 Clark Iii William T Expanding mesh catheter
JPS6037734B2 (en) 1978-10-12 1985-08-28 Sumitomo Electric Industries
GB2069339B (en) 1980-02-18 1983-08-10 Keymed Medicals & Ind Equip Endo-oesophageal tube
NL8220336A (en) 1981-09-16 1984-01-02 Wallsten Hans Ivar Device for use in blood vessels or other difficult to reach places, and its use.
FR2513111B3 (en) 1981-09-23 1984-07-20 Girault Francois
US5067957A (en) 1983-10-14 1991-11-26 Raychem Corporation Method of inserting medical devices incorporating SIM alloy elements
US4560374A (en) 1983-10-17 1985-12-24 Hammerslag Julius G Method for repairing stenotic vessels
EP0275535A1 (en) 1986-12-23 1988-07-27 Baykut, Doguhan, Dr. med. Heart valve prosthesis
US4699611A (en) 1985-04-19 1987-10-13 C. R. Bard, Inc. Biliary stent introducer
US4878906A (en) 1986-03-25 1989-11-07 Servetus Partnership Endoprosthesis for repairing a damaged vessel
US4793348A (en) 1986-11-15 1988-12-27 Palmaz Julio C Balloon expandable vena cava filter to prevent migration of lower extremity venous clots into the pulmonary circulation
US4969458A (en) 1987-07-06 1990-11-13 Medtronic, Inc. Intracoronary stent and method of simultaneous angioplasty and stent implant
US4886062A (en) 1987-10-19 1989-12-12 Medtronic, Inc. Intravascular radially expandable stent and method of implant
US4877030A (en) 1988-02-02 1989-10-31 Andreas Beck Device for the widening of blood vessels
DE8905127U1 (en) 1989-04-24 1989-07-13 Spiegelberg Kg, 2100 Hamburg, De
US4973301A (en) 1989-07-11 1990-11-27 Israel Nissenkorn Catheter and method of using same
US5057092A (en) 1990-04-04 1991-10-15 Webster Wilton W Jr Braided catheter with low modulus warp
US5071407A (en) 1990-04-12 1991-12-10 Schneider (U.S.A.) Inc. Radially expandable fixation member
US5158548A (en) 1990-04-25 1992-10-27 Advanced Cardiovascular Systems, Inc. Method and system for stent delivery
US5360443A (en) 1990-06-11 1994-11-01 Barone Hector D Aortic graft for repairing an abdominal aortic aneurysm
US5064435A (en) 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
US5258000A (en) 1991-11-25 1993-11-02 Cook Incorporated Tissue aperture repair device
US5817102A (en) 1992-05-08 1998-10-06 Schneider (Usa) Inc. Apparatus for delivering and deploying a stent
US5843170A (en) 1994-09-02 1998-12-01 Ahn; Sam Seunghae Apparatus and method for performing aneurysm repair
JP3198844B2 (en) 1994-12-27 2001-08-13 日産自動車株式会社 Protection cap structure and mounting method for a motor vehicle
WO1996025897A3 (en) 1995-02-22 1996-11-21 Menlo Care Inc Covered expanding mesh stent
US5667523A (en) 1995-04-28 1997-09-16 Impra, Inc. Dual supported intraluminal graft
DK0955950T3 (en) 1996-01-04 2006-07-31 Timothy A M Dr Chuter Flat Wire Stent
US5843158A (en) 1996-01-05 1998-12-01 Medtronic, Inc. Limited expansion endoluminal prostheses and methods for their use
US5824042A (en) 1996-04-05 1998-10-20 Medtronic, Inc. Endoluminal prostheses having position indicating markers
US6241757B1 (en) 1997-02-04 2001-06-05 Solco Surgical Instrument Co., Ltd. Stent for expanding body's lumen
JP2002531169A (en) * 1998-08-31 2002-09-24 ウイルソンークック メディカル インク. Anti-reflux esophageal prosthesis

Patent Citations (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868956A (en) * 1972-06-05 1975-03-04 Ralph J Alfidi Vessel implantable appliance and method of implanting it
US3890977A (en) * 1974-03-01 1975-06-24 Bruce C Wilson Kinetic memory electrodes, catheters and cannulae
US4149911A (en) * 1977-01-24 1979-04-17 Raychem Limited Memory metal article
US4271827A (en) * 1979-09-13 1981-06-09 Angelchik Jean P Method for prevention of gastro esophageal reflux
US4729766A (en) * 1980-08-28 1988-03-08 Astra Meditec Aktiebolag Vascular prosthesis and method in producing it
US4425908A (en) * 1981-10-22 1984-01-17 Beth Israel Hospital Blood clot filter
US4445896A (en) * 1982-03-18 1984-05-01 Cook, Inc. Catheter plug
US4655771B1 (en) * 1982-04-30 1996-09-10 Medinvent Ams Sa Prosthesis comprising an expansible or contractile tubular body
US4655771A (en) * 1982-04-30 1987-04-07 Shepherd Patents S.A. Prosthesis comprising an expansible or contractile tubular body
US4494531A (en) * 1982-12-06 1985-01-22 Cook, Incorporated Expandable blood clot filter
US4512338A (en) * 1983-01-25 1985-04-23 Balko Alexander B Process for restoring patency to body vessels
US4503569A (en) * 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US4719916A (en) * 1983-10-03 1988-01-19 Biagio Ravo Intraintestinal bypass tube
US4572186A (en) * 1983-12-07 1986-02-25 Cordis Corporation Vessel dilation
US4636313A (en) * 1984-02-03 1987-01-13 Vaillancourt Vincent L Flexible filter disposed within flexible conductor
US4657530A (en) * 1984-04-09 1987-04-14 Henry Buchwald Compression pump-catheter
US4687468A (en) * 1984-10-01 1987-08-18 Cook, Incorporated Implantable insulin administration device
US4580568A (en) * 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4732152A (en) * 1984-12-05 1988-03-22 Medinvent S.A. Device for implantation and a method of implantation in a vessel using such device
US4825861A (en) * 1985-05-04 1989-05-02 Walter Koss Of Industriestrasse Endotube
US4733665B1 (en) * 1985-11-07 1994-01-11 Expandable Grafts Partnership Expandable intraluminal graft,and method and apparatus for implanting an expandable intraluminal graft
US4739762A (en) * 1985-11-07 1988-04-26 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4733665C2 (en) * 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4733665A (en) * 1985-11-07 1988-03-29 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4739762B1 (en) * 1985-11-07 1998-10-27 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4922905A (en) * 1985-11-30 1990-05-08 Strecker Ernst P Dilatation catheter
US4681110A (en) * 1985-12-02 1987-07-21 Wiktor Dominik M Catheter arrangement having a blood vessel liner, and method of using it
US4665918A (en) * 1986-01-06 1987-05-19 Garza Gilbert A Prosthesis system and method
US4649922A (en) * 1986-01-23 1987-03-17 Wiktor Donimik M Catheter arrangement having a variable diameter tip and spring prosthesis
US4768507A (en) * 1986-02-24 1988-09-06 Medinnovations, Inc. Intravascular stent and percutaneous insertion catheter system for the dilation of an arterial stenosis and the prevention of arterial restenosis
US4716900A (en) * 1986-05-09 1988-01-05 Pfizer Hospital Products Group, Inc. Intraintestinal bypass graft
US4723549A (en) * 1986-09-18 1988-02-09 Wholey Mark H Method and apparatus for dilating blood vessels
US4957508A (en) * 1986-10-31 1990-09-18 Ube Industries, Ltd. Medical tubes
US4848343A (en) * 1986-10-31 1989-07-18 Medinvent S.A. Device for transluminal implantation
US4762128A (en) * 1986-12-09 1988-08-09 Advanced Surgical Intervention, Inc. Method and apparatus for treating hypertrophy of the prostate gland
US4907336A (en) * 1987-03-13 1990-03-13 Cook Incorporated Method of making an endovascular stent and delivery system
US5314444A (en) * 1987-03-13 1994-05-24 Cook Incorporated Endovascular stent and delivery system
US4800882A (en) * 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US5041126A (en) * 1987-03-13 1991-08-20 Cook Incorporated Endovascular stent and delivery system
US4794928A (en) * 1987-06-10 1989-01-03 Kletschka Harold D Angioplasty device and method of using the same
US5133732A (en) * 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US5653727A (en) * 1987-10-19 1997-08-05 Medtronic, Inc. Intravascular stent
US4820298A (en) * 1987-11-20 1989-04-11 Leveen Eric G Internal vascular prosthesis
US5019102A (en) * 1987-12-10 1991-05-28 Eberhard Hoene Anti-refluxive internal ureteral stent with a dynamic hood-valve at the vesical end for prevention of urinary reflux into the upper urinary tract upon increase of vesical pressure
US4830003A (en) * 1988-06-17 1989-05-16 Wolff Rodney G Compressive stent and delivery system
US4921484A (en) * 1988-07-25 1990-05-01 Cordis Corporation Mesh balloon catheter device
US5019090A (en) * 1988-09-01 1991-05-28 Corvita Corporation Radially expandable endoprosthesis and the like
US4846836A (en) * 1988-10-03 1989-07-11 Reich Jonathan D Artificial lower gastrointestinal valve
US4913141A (en) * 1988-10-25 1990-04-03 Cordis Corporation Apparatus and method for placement of a stent within a subject vessel
US4856516A (en) * 1989-01-09 1989-08-15 Cordis Corporation Endovascular stent apparatus and method
US4955899A (en) * 1989-05-26 1990-09-11 Impra, Inc. Longitudinally compliant vascular graft
US5500014A (en) * 1989-05-31 1996-03-19 Baxter International Inc. Biological valvular prothesis
US5015253A (en) * 1989-06-15 1991-05-14 Cordis Corporation Non-woven endoprosthesis
US5026377A (en) * 1989-07-13 1991-06-25 American Medical Systems, Inc. Stent placement instrument and method
US5314473A (en) * 1989-07-20 1994-05-24 Godin Norman J Prosthesis for preventing gastric reflux into the esophagus
US5879382A (en) * 1989-08-24 1999-03-09 Boneau; Michael D. Endovascular support device and method
US5035706A (en) * 1989-10-17 1991-07-30 Cook Incorporated Percutaneous stent and method for retrieval thereof
US5089006A (en) * 1989-11-29 1992-02-18 Stiles Frank B Biological duct liner and installation catheter
US5108416A (en) * 1990-02-13 1992-04-28 C. R. Bard, Inc. Stent introducer system
US5413601A (en) * 1990-03-26 1995-05-09 Keshelava; Viktor V. Tubular organ prosthesis
US5378239A (en) * 1990-04-12 1995-01-03 Schneider (Usa) Inc. Radially expandable fixation member constructed of recovery metal
US5496277A (en) * 1990-04-12 1996-03-05 Schneider (Usa) Inc. Radially expandable body implantable device
US5221261A (en) * 1990-04-12 1993-06-22 Schneider (Usa) Inc. Radially expandable fixation member
US5123917A (en) * 1990-04-27 1992-06-23 Lee Peter Y Expandable intraluminal vascular graft
US5078736A (en) * 1990-05-04 1992-01-07 Interventional Thermodynamics, Inc. Method and apparatus for maintaining patency in the body passages
US5411552A (en) * 1990-05-18 1995-05-02 Andersen; Henning R. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
US5282824A (en) * 1990-10-09 1994-02-01 Cook, Incorporated Percutaneous stent assembly
US5330500A (en) * 1990-10-18 1994-07-19 Song Ho Y Self-expanding endovascular stent with silicone coating
US5316543A (en) * 1990-11-27 1994-05-31 Cook Incorporated Medical apparatus and methods for treating sliding hiatal hernias
US5112900A (en) * 1990-11-28 1992-05-12 Tactyl Technologies, Inc. Elastomeric triblock copolymer compositions and articles made therewith
US5135536A (en) * 1991-02-05 1992-08-04 Cordis Corporation Endovascular stent and method
US5876445A (en) * 1991-10-09 1999-03-02 Boston Scientific Corporation Medical stents for body lumens exhibiting peristaltic motion
US5662713A (en) * 1991-10-09 1997-09-02 Boston Scientific Corporation Medical stents for body lumens exhibiting peristaltic motion
US5316023A (en) * 1992-01-08 1994-05-31 Expandable Grafts Partnership Method for bilateral intra-aortic bypass
US5176626A (en) * 1992-01-15 1993-01-05 Wilson-Cook Medical, Inc. Indwelling stent
USRE35849E (en) * 1992-01-15 1998-07-14 Wilson-Cook Medical, Inc. Indwelling stent
US5405377A (en) * 1992-02-21 1995-04-11 Endotech Ltd. Intraluminal stent
US5665115A (en) * 1992-02-21 1997-09-09 Boston Scientific Technology, Inc. Intraluminal stent
US5755769A (en) * 1992-03-12 1998-05-26 Laboratoire Perouse Implant Expansible endoprosthesis for a human or animal tubular organ, and fitting tool for use thereof
US5282823A (en) * 1992-03-19 1994-02-01 Medtronic, Inc. Intravascular radially expandable stent
US5876448A (en) * 1992-05-08 1999-03-02 Schneider (Usa) Inc. Esophageal stent
US5645559A (en) * 1992-05-08 1997-07-08 Schneider (Usa) Inc Multiple layer stent
US5507771A (en) * 1992-06-15 1996-04-16 Cook Incorporated Stent assembly
US5306300A (en) * 1992-09-22 1994-04-26 Berry H Lee Tubular digestive screen
US5443499A (en) * 1993-01-14 1995-08-22 Meadox Medicals, Inc. Radially expandable tubular prosthesis
US5334210A (en) * 1993-04-09 1994-08-02 Cook Incorporated Vascular occlusion assembly
US5534287A (en) * 1993-04-23 1996-07-09 Schneider (Europe) A.G. Methods for applying an elastic coating layer on stents
US5545211A (en) * 1993-09-27 1996-08-13 Sooho Medi-Tech Co., Ltd. Stent for expanding a lumen
US5782904A (en) * 1993-09-30 1998-07-21 Endogad Research Pty Limited Intraluminal graft
US5733325A (en) * 1993-11-04 1998-03-31 C. R. Bard, Inc. Non-migrating vascular prosthesis and minimally invasive placement system
US5405316A (en) * 1993-11-17 1995-04-11 Magram; Gary Cerebrospinal fluid shunt
US5716393A (en) * 1994-05-26 1998-02-10 Angiomed Gmbh & Co. Medizintechnik Kg Stent with an end of greater diameter than its main body
US5861036A (en) * 1995-03-28 1999-01-19 Biomedix S.A. Switzerland Medical prosthesis for preventing gastric reflux in the esophagus
US5741333A (en) * 1995-04-12 1998-04-21 Corvita Corporation Self-expanding stent for a medical device to be introduced into a cavity of a body
US5746766A (en) * 1995-05-09 1998-05-05 Edoga; John K. Surgical stent
US5788626A (en) * 1995-11-21 1998-08-04 Schneider (Usa) Inc Method of making a stent-graft covered with expanded polytetrafluoroethylene
US5922019A (en) * 1995-11-27 1999-07-13 Schneider (Europe) A.G. Conical stent
US6027525A (en) * 1996-05-23 2000-02-22 Samsung Electronics., Ltd. Flexible self-expandable stent and method for making the same
US5647843A (en) * 1996-05-24 1997-07-15 Vance Products Incorporated Anti-reflux ureteral stent
US6010529A (en) * 1996-12-03 2000-01-04 Atrium Medical Corporation Expandable shielded vessel support
US5733330A (en) * 1997-01-13 1998-03-31 Advanced Cardiovascular Systems, Inc. Balloon-expandable, crush-resistant locking stent
US5876450A (en) * 1997-05-09 1999-03-02 Johlin, Jr.; Frederick C. Stent for draining the pancreatic and biliary ducts and instrumentation for the placement thereof
US6264700B1 (en) * 1998-08-27 2001-07-24 Endonetics, Inc. Prosthetic gastroesophageal valve

Cited By (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006083763A1 (en) * 2005-01-31 2006-08-10 Wilson-Cook Medical Inc. Prosthesis having a sleeve valve
US9308077B2 (en) 2005-12-23 2016-04-12 Vysera Biomedical Limited Medical device suitable for treating reflux from a stomach to an oesophagus
US20070198048A1 (en) * 2005-12-23 2007-08-23 Niall Behan Medical device suitable for treating reflux from a stomach to an oesophagus
US8603189B2 (en) 2005-12-23 2013-12-10 Vysera Biomedical Limited Medical device suitable for treating reflux from a stomach to an oesophagus
US20100298951A1 (en) * 2005-12-23 2010-11-25 Vysera Biomedical Limited Medical device suitable for treating reflux from a stomach to an oesophagus
US8603188B2 (en) 2005-12-23 2013-12-10 Vysera Biomedical Limited Medical device suitable for treating reflux from a stomach to an oesophagus
US20100036504A1 (en) * 2005-12-23 2010-02-11 Vysera Biomedical Limited Valve
US20100280613A1 (en) * 2005-12-23 2010-11-04 Vysera Biomedical Limited Medical device suitable for treating reflux from a stomach to an oesophagus
US20070282452A1 (en) * 2006-05-30 2007-12-06 Boston Scientific Scimed, Inc. Anti-obesity dual stent
US20110172585A1 (en) * 2006-05-30 2011-07-14 Boston Scientific Scimed, Inc. Anti-obesity dual stent
US7922684B2 (en) * 2006-05-30 2011-04-12 Boston Scientific Scimed, Inc. Anti-obesity dual stent
US9597173B2 (en) 2006-05-30 2017-03-21 Boston Scientific Scimed, Inc. Anti-obesity dual stent
WO2008103572A1 (en) * 2007-02-22 2008-08-28 Wilson-Cook Medical Inc. Prosthesis having a sleeve valve
US8221505B2 (en) * 2007-02-22 2012-07-17 Cook Medical Technologies Llc Prosthesis having a sleeve valve
US20090143713A1 (en) * 2007-11-30 2009-06-04 Jacques Van Dam Biliary Shunts, Delivery Systems, Methods of Using the Same and Kits Therefor
US20090143759A1 (en) * 2007-11-30 2009-06-04 Jacques Van Dam Methods, Devices, Kits and Systems for Defunctionalizing the Cystic Duct
US9282968B2 (en) 2007-11-30 2016-03-15 Treus Medical, Inc. Applicator for endoscopic treatment of biliary disease
US9486219B2 (en) 2007-11-30 2016-11-08 Treus Medical, Inc. Biliary shunts, delivery systems, methods of using the same and kits therefor
US20090143760A1 (en) * 2007-11-30 2009-06-04 Jacques Van Dam Methods, Devices, Kits and Systems for Defunctionalizing the Gallbladder
US20110160836A1 (en) * 2008-06-20 2011-06-30 Vysera Biomedical Limited Valve device
US8500821B2 (en) 2008-06-20 2013-08-06 Vysera Biomedical Limited Esophageal valve device for placing in the cardia
US20100114327A1 (en) * 2008-06-20 2010-05-06 Vysera Biomedical Limited Valve
US8673020B2 (en) 2008-06-20 2014-03-18 Vysera Biomedical Limited Esophageal valve device for placing in the cardia
US8029557B2 (en) 2008-06-20 2011-10-04 Vysera Biomedical Limited Esophageal valve
US8211186B2 (en) 2009-04-03 2012-07-03 Metamodix, Inc. Modular gastrointestinal prostheses
US8702641B2 (en) 2009-04-03 2014-04-22 Metamodix, Inc. Gastrointestinal prostheses having partial bypass configurations
US9962278B2 (en) 2009-04-03 2018-05-08 Metamodix, Inc. Modular gastrointestinal prostheses
US9044300B2 (en) 2009-04-03 2015-06-02 Metamodix, Inc. Gastrointestinal prostheses
US9173760B2 (en) 2009-04-03 2015-11-03 Metamodix, Inc. Delivery devices and methods for gastrointestinal implants
US9278019B2 (en) 2009-04-03 2016-03-08 Metamodix, Inc Anchors and methods for intestinal bypass sleeves
US9901347B2 (en) 2009-05-29 2018-02-27 Terus Medical, Inc. Biliary shunts, delivery systems, and methods of using the same
US20110054381A1 (en) * 2009-05-29 2011-03-03 Jacques Van Dam Biliary shunts, delivery systems, and methods of using the same
US8282598B2 (en) 2009-07-10 2012-10-09 Metamodix, Inc. External anchoring configurations for modular gastrointestinal prostheses
US8702642B2 (en) 2009-07-10 2014-04-22 Metamodix, Inc. External anchoring configurations for modular gastrointestinal prostheses
US9498314B2 (en) 2009-12-18 2016-11-22 Coloplast A/S Urological device
US8876800B2 (en) 2009-12-18 2014-11-04 Vysera Biomedical Limited Urological device
US9585740B2 (en) 2010-11-03 2017-03-07 Coloplast A/S Urological device
US8992410B2 (en) 2010-11-03 2015-03-31 Vysera Biomedical Limited Urological device
US9585742B2 (en) * 2013-07-11 2017-03-07 Olympus Corporation Stent
US20160128824A1 (en) * 2013-07-11 2016-05-12 Olympus Corporation Stent
US9622897B1 (en) 2016-03-03 2017-04-18 Metamodix, Inc. Pyloric anchors and methods for intestinal bypass sleeves

Also Published As

Publication number Publication date Type
US20020032487A1 (en) 2002-03-14 application
US6746489B2 (en) 2004-06-08 grant

Similar Documents

Publication Publication Date Title
US7615072B2 (en) Endoluminal prosthesis
US7766973B2 (en) Eversion resistant sleeves
US8282598B2 (en) External anchoring configurations for modular gastrointestinal prostheses
US6767358B2 (en) Apparatus for engrafting a blood vessel
US5961548A (en) Bifurcated two-part graft and methods of implantation
US7128759B2 (en) Implantable medical device with constrained expansion
US5782838A (en) Cytoscope delivery system
US6676699B2 (en) Stent graft with integrated valve device and method
US20090030497A1 (en) Retention Wire For Self-Expanding Stent
US7232459B2 (en) Thoracic aortic aneurysm stent graft
US20020052644A1 (en) Implantable vascular graft
US20040249362A1 (en) Enzyme sleeve
US7766861B2 (en) Anti-obesity devices
US7413573B2 (en) Fenestrated stent grafts
US20040193283A1 (en) Longitudinally expanding medical device
US7837669B2 (en) Devices and methods for endolumenal gastrointestinal bypass
US20050085900A1 (en) Prosthetic valve for implantation in a body vessel
US4271827A (en) Method for prevention of gastro esophageal reflux
US7335224B2 (en) Stent graft retention system
US20030163204A1 (en) Stent
US20070282453A1 (en) Anti-obesity stent
US5372600A (en) Stent delivery systems
US20080065205A1 (en) Retrievable implant and method for treatment of mitral regurgitation
US20130079603A1 (en) Intragastric implant devices
Strecker et al. Malignant duodenal stenosis: palliation with peroral implantation of a self-expanding nitinol stent.